
Oncolytics Biotech® Provides Positive Safety Update on the Pancreatic Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial
February 2, 2022
Host Carmel Fisher interviews CEO: Jared Wolfson. He tells us about Santa.com, and the upcoming features in Grom Social services and products.